RDX-8940

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameRDX-8940
Drug Alias NameRDX8940
ClassificationOther
Mechanisms of ActionG-protein coupled bile acid receptor 1 agonists
TargetsG-protein coupled bile acid receptor 1
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArdelyx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArdelyx Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A